Radiosensitizing effect of zoledronic acid in small cell lung cancer
Authors:
- A. Ugur UralAUA. Ugur Ural
- Ferit AvcuFAFerit Avcu
- 30 November 2005
- journal article
- other
- Published by Elsevier in Lung Cancer
- Vol. 50 (2) , 271-272
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The bisphosphonate zoledronic acid inhibits the development of plasmacytoma induced in BALB/c mice by intraperitoneal injection of pristaneEuropean Journal of Haematology, 2005
- Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate cancer and myeloma cell linesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell linesLung Cancer, 2005
- p53‐independent anti‐tumor effects of the nitrogen‐containing bisphosphonate zoledronic acidCancer Science, 2004
- The Bisphosphonate Zoledronic Acid Induces Cytotoxicity in Human Myeloma Cell Lines with Enhancing Effects of Dexamethasone and ThalidomideInternational Journal of Hematology, 2003
- The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph+ leukemia activity of imatinib mesylateBlood, 2003
- Antitumor effects of bisphosphonatesCancer, 2003
- Bisphosphonate therapy in multiple myeloma: past, present, futureEuropean Journal of Haematology, 2002
- Cellular and molecular mechanisms of action of bisphosphonatesCancer, 2000
- Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997